Regulatory News

Director/PDMR Shareholding

Wed, 9th Jan 2013 17:26

RNS Number : 2130V

GlaxoSmithKline PLC

09 January 2013

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline UK and US Performance Share Plans notified the Company and the under-mentioned Connected Persons on 8 January 2013 of the following increases in their notional interests in Ordinary Shares at a price of 1363.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $43.98 per ADS following the notional re-investment of the dividend paid to shareholders on 3 January 2013.

Director/PDMR

Connected Person

Ordinary Shares

ADSs

Dr M M Slaoui

Dr K Slaoui

22.521

Mr P C Thomson

Mrs K Thomson

56.689

The notional dividends accrued will be paid out in proportion to the percentage of the participant's Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).

V A Whyte

Company Secretary

9 January 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSDKLFBXFFLBBZ

Related Shares: GlaxoSmithKline (GSK).

Back to Regulatory News

Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.